BR9810026A - Composição de vacina, uso de um polipeptìdeo flge de helicobacter pylori ou uma sua forma modificada, uso do mesmo, composição de vacina para induzir uma resposta imune protetora para a infecção do helicobacter pylori, processo de diagnose in vitro da infecção do helicobacter pylori, kit de diagnóstico para a detecção de infecção de helicobacter pylori em um mamìfero incluindo o homem, e, processo para extrair em um mamìfero uma resposta imune protetora contra a infecção pelo helicobacter pylori - Google Patents
Composição de vacina, uso de um polipeptìdeo flge de helicobacter pylori ou uma sua forma modificada, uso do mesmo, composição de vacina para induzir uma resposta imune protetora para a infecção do helicobacter pylori, processo de diagnose in vitro da infecção do helicobacter pylori, kit de diagnóstico para a detecção de infecção de helicobacter pylori em um mamìfero incluindo o homem, e, processo para extrair em um mamìfero uma resposta imune protetora contra a infecção pelo helicobacter pyloriInfo
- Publication number
- BR9810026A BR9810026A BR9810026-2A BR9810026A BR9810026A BR 9810026 A BR9810026 A BR 9810026A BR 9810026 A BR9810026 A BR 9810026A BR 9810026 A BR9810026 A BR 9810026A
- Authority
- BR
- Brazil
- Prior art keywords
- helicobacter pylori
- pylori infection
- immune response
- protective immune
- vaccine composition
- Prior art date
Links
- 206010019375 Helicobacter infections Diseases 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 8
- 239000000203 mixture Substances 0.000 title abstract 5
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 230000001681 protective effect Effects 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 241000590002 Helicobacter pylori Species 0.000 title abstract 3
- 229940037467 helicobacter pylori Drugs 0.000 title abstract 3
- 230000028993 immune response Effects 0.000 title abstract 3
- 238000000338 in vitro Methods 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 title 2
- 238000002405 diagnostic procedure Methods 0.000 title 1
- 238000003745 diagnosis Methods 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56922—Campylobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702242A SE9702242D0 (sv) | 1997-06-12 | 1997-06-12 | Vaccine compositions V |
| PCT/SE1998/001093 WO1998056816A1 (en) | 1997-06-12 | 1998-06-08 | VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI FlgE POLYPEPTIDE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9810026A true BR9810026A (pt) | 2000-09-19 |
Family
ID=20407351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9810026-2A BR9810026A (pt) | 1997-06-12 | 1998-06-08 | Composição de vacina, uso de um polipeptìdeo flge de helicobacter pylori ou uma sua forma modificada, uso do mesmo, composição de vacina para induzir uma resposta imune protetora para a infecção do helicobacter pylori, processo de diagnose in vitro da infecção do helicobacter pylori, kit de diagnóstico para a detecção de infecção de helicobacter pylori em um mamìfero incluindo o homem, e, processo para extrair em um mamìfero uma resposta imune protetora contra a infecção pelo helicobacter pylori |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1009764A1 (zh) |
| JP (1) | JP2002507118A (zh) |
| KR (1) | KR20010013699A (zh) |
| CN (1) | CN1259960A (zh) |
| AR (1) | AR012896A1 (zh) |
| AU (1) | AU8048798A (zh) |
| BR (1) | BR9810026A (zh) |
| CA (1) | CA2293293A1 (zh) |
| EE (1) | EE9900566A (zh) |
| HU (1) | HUP0003164A3 (zh) |
| ID (1) | ID23052A (zh) |
| IL (1) | IL133144A0 (zh) |
| IS (1) | IS5288A (zh) |
| NO (1) | NO996132L (zh) |
| NZ (1) | NZ501427A (zh) |
| PL (1) | PL337503A1 (zh) |
| SE (1) | SE9702242D0 (zh) |
| SK (1) | SK173099A3 (zh) |
| TR (1) | TR199903060T2 (zh) |
| WO (1) | WO1998056816A1 (zh) |
| ZA (1) | ZA984696B (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104784687A (zh) * | 2015-04-27 | 2015-07-22 | 苏州大学附属第一医院 | 重组绿脓杆菌鞭毛钩蛋白FlgE的用途 |
| CN113425717B (zh) * | 2021-04-22 | 2023-06-16 | 成都欧林生物科技股份有限公司 | 一种提高口服幽门螺杆菌疫苗效力的药剂及其应用 |
| CN116535472B (zh) * | 2023-05-31 | 2024-04-30 | 四川大学华西医院 | 一种幽门螺杆菌重组蛋白抗原FlgK及其制备方法与应用 |
| CN118105473B (zh) * | 2024-04-30 | 2024-08-16 | 成都欧林生物科技股份有限公司 | 一种预防或治疗Hp感染口服免疫原性组合物及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5459041A (en) * | 1988-02-18 | 1995-10-17 | Enteric Research Laboratories, Inc. | Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection |
| AR003125A1 (es) * | 1995-06-01 | 1998-07-08 | Astra Ab | Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la |
-
1997
- 1997-06-12 SE SE9702242A patent/SE9702242D0/xx unknown
-
1998
- 1998-06-01 ZA ZA984696A patent/ZA984696B/xx unknown
- 1998-06-01 AR ARP980102558A patent/AR012896A1/es unknown
- 1998-06-08 SK SK1730-99A patent/SK173099A3/sk unknown
- 1998-06-08 EE EEP199900566A patent/EE9900566A/xx unknown
- 1998-06-08 EP EP98928772A patent/EP1009764A1/en not_active Withdrawn
- 1998-06-08 CA CA002293293A patent/CA2293293A1/en not_active Abandoned
- 1998-06-08 PL PL98337503A patent/PL337503A1/xx unknown
- 1998-06-08 IL IL13314498A patent/IL133144A0/xx unknown
- 1998-06-08 CN CN98806101A patent/CN1259960A/zh active Pending
- 1998-06-08 NZ NZ501427A patent/NZ501427A/xx unknown
- 1998-06-08 AU AU80487/98A patent/AU8048798A/en not_active Abandoned
- 1998-06-08 KR KR1019997011714A patent/KR20010013699A/ko not_active Application Discontinuation
- 1998-06-08 ID IDW991542A patent/ID23052A/id unknown
- 1998-06-08 TR TR1999/03060T patent/TR199903060T2/xx unknown
- 1998-06-08 HU HU0003164A patent/HUP0003164A3/hu unknown
- 1998-06-08 JP JP50228399A patent/JP2002507118A/ja active Pending
- 1998-06-08 WO PCT/SE1998/001093 patent/WO1998056816A1/en not_active Application Discontinuation
- 1998-06-08 BR BR9810026-2A patent/BR9810026A/pt not_active IP Right Cessation
-
1999
- 1999-12-08 IS IS5288A patent/IS5288A/is unknown
- 1999-12-10 NO NO996132A patent/NO996132L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO996132L (no) | 2000-01-28 |
| JP2002507118A (ja) | 2002-03-05 |
| NO996132D0 (no) | 1999-12-10 |
| WO1998056816A1 (en) | 1998-12-17 |
| EP1009764A1 (en) | 2000-06-21 |
| AU8048798A (en) | 1998-12-30 |
| PL337503A1 (en) | 2000-08-28 |
| CA2293293A1 (en) | 1998-12-17 |
| IS5288A (is) | 1999-12-08 |
| CN1259960A (zh) | 2000-07-12 |
| ID23052A (id) | 2000-01-20 |
| HUP0003164A2 (hu) | 2000-12-28 |
| ZA984696B (en) | 1999-01-04 |
| HUP0003164A3 (en) | 2001-10-29 |
| TR199903060T2 (xx) | 2000-09-21 |
| EE9900566A (xx) | 2000-06-15 |
| SE9702242D0 (sv) | 1997-06-12 |
| SK173099A3 (en) | 2000-06-12 |
| AR012896A1 (es) | 2000-11-22 |
| KR20010013699A (ko) | 2001-02-26 |
| NZ501427A (en) | 2000-09-29 |
| IL133144A0 (en) | 2001-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zahradnik et al. | In vitro enamel demineralization by Streptococcus mutans in the presence of salivary pellicles | |
| ATE247985T1 (de) | Einführung einer thiol-gruppe in proteine für die radioimmundetektion und radioimmuntherapie auf der basis von radionukliden | |
| CY1109024T1 (el) | Πρωτεϊνες streptococcus pneumoniae και ανοσογονικα θραυσματα για εμβολια | |
| DE69637914D1 (de) | Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus | |
| MX9203278A (es) | Pastilla de liberacion sustentada que comprende loratadina, ibuprofen y pseudoefedrina. | |
| IT1237764B (it) | Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici. | |
| EP0909814A3 (en) | Use of protein kinases for the diagnosis and treatment of Alzheimer's disease | |
| EP0683234A4 (en) | ANTIBODIES DIRECTED AGAINST -g (b) -AMYLOID OR A DERIVATIVE THEREOF AND ITS USE. | |
| ES8801318A1 (es) | Un procedimiento para la produccion de un peptido. | |
| BR9916020A (pt) | Compostos e métodos para o tratamento e diagnóstico de infecção por chlamydia | |
| BR9814473A (pt) | Imunógenos anti-retrovirais, preparação e uso | |
| FI902143A0 (fi) | Hiv-peptider, artificiella hiv -antigener och immunobestaemningsfoerpackningar. | |
| NO902280L (no) | Ny poroes farmasoeytisk form og fremstilling derav. | |
| Erickson et al. | Purification and partial characterization of a 65-kDa platelet aggregation-associated protein antigen from the surface of Streptococcus sanguis. | |
| BR9810907A (pt) | Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico | |
| UA42040C2 (uk) | Поліпептид, спосіб діагностики інсулінозалежного цукрового діабету (iddm), що розвинувся або що розвивається (варіанти), набір для діагностики iddm (варіанти), препарат для запобігання або лікування iddm, фармацевтична композиція для профілактики або лікування iddm | |
| BR9810026A (pt) | Composição de vacina, uso de um polipeptìdeo flge de helicobacter pylori ou uma sua forma modificada, uso do mesmo, composição de vacina para induzir uma resposta imune protetora para a infecção do helicobacter pylori, processo de diagnose in vitro da infecção do helicobacter pylori, kit de diagnóstico para a detecção de infecção de helicobacter pylori em um mamìfero incluindo o homem, e, processo para extrair em um mamìfero uma resposta imune protetora contra a infecção pelo helicobacter pylori | |
| BR0215081A (pt) | Proteìnas purificadas do envoltório do vìrus de hepatite c para uso diagnóstico e terapêutico | |
| BR0207018A (pt) | Leptina modificada com imunogenicidade reduzida | |
| DE3879085D1 (de) | Snrnp-a-antigen und fragmente davon. | |
| Yamaguchi et al. | Preparation and characterization of an Actinomyces naeslundii aggregation factor that mediates coaggregation with Porphyromonas gingivalis | |
| ES2059418T3 (es) | Antigeno asociado a carcinoma humano y anticuerpo asociado al antigeno. | |
| DK0454813T3 (da) | Caseinfraktion til terapeutisk, profylaktisk og/eller diagnostisk anvendelse ved infektioner i åndedrætssystemet | |
| ES2057572T3 (es) | Agentes de reconocimiento. | |
| BR9916549A (pt) | Composição farmacêutica, vacina, proteìna, e, método para a prevenção ou tratamento de leishmaniose em um humano ou animal |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A,6A,7A,8A E 9A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007. |